Schnorr, Isabel
Siegl, Anne
Luckhardt, Sonja
Wenz, Söri
Friedrichsen, Hendrik
El Jomaa, Hiba
Steinmann, Annebirth
Kilencz, Tünde
Arteaga-Henríquez, Gara
Ramos-Sayalero, Carolina
Ibanez-Jimenez, Pol
Rosales-Ortiz, Silvia Karina
Bitter, István http://orcid.org/0000-0002-9464-4709
Fadeuilhe, Christian
Ferrer, Marc
Lavebratt, Catharina http://orcid.org/0000-0003-4987-2718
Réthelyi, János M.
Richarte, Vanesa
Rommelse, Nanda
Ramos-Quiroga, Josep Antoni http://orcid.org/0000-0003-1622-0350
Arias-Vasquez, Alejandro http://orcid.org/0000-0002-4786-0169
Resch, Eduard
Reif, Andreas http://orcid.org/0000-0002-0992-634X
Matura, Silke
Schiweck, Carmen http://orcid.org/0000-0003-4215-0448
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (728018, 728018, 728018, 728018, 728018, 728018, 728018, 728018, 667302, 964215, 728018)
Article History
Received: 11 August 2023
Revised: 8 December 2023
Accepted: 22 December 2023
First Online: 18 January 2024
Competing interests
: IS, AS, SL, SW, HF, HEJ, AS, TK, CRS, PIJ, SKRO, CF, MF, CL, JMR, VR, NR, AAV, ER, SM, and CS do not report any conflict of interest. GAH reported receiving personal fees from Janssen outside the submitted work. IB reported receiving consulting fees from Gedeon Richter and Janssen/Janssen-Cilag; speaker’s honoraria from Gedeon Richter, Hikma Pharmaceuticals, Janssen/Janssen-Cilag, KRKA, Lundbeck, and Medichem Pharmaceuticals Inc. by Unilab; research grant from Gedeon Richter; royalties from Oxford University Press. AR reported receiving personal fees from Medice, Shire/Takeda, SAGE/Biogen, Boehringen Ingelheim, Janssen, and Cyclerion outside the submitted work and funding from the European Union’s Horizon 2020 Research and Innovation Program under grant agreement No. 667302 and 964215. JARQ reported being on the speakers’ bureau and/or having acted as a consultant for Janssen-Cilag, Novartis, Shire, Takeda, Bial, Shionogi, Sincrolab, Novartis, BMS, Medice, Rubió, Uriach, Technofarma and Rafo, received travel awards (air tickets + hotel) from Janssen-Cilag, Rubió, Shire, Takeda, Shionogi, Bial and Medice for taking part in psychiatric meetings, outside the submitted work.